L-MOCA: An open-label study of olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer.

Qinglei Gao,Jianqing Zhu,Weidong Zhao,Yi Huang,Ruifang An,Hong Zheng,Pengpeng Qu,Li Wang,Qi Zhou,Danbo Wang,Ge Lou,Jian Wang,J.S.H. Low,Beihua Kong,Rutie Yin,Xing Xie,Jihong Liu,Wei Sun,Rongyu Zang,Ding Ma

L-MOCA: An open-label study of olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer.

2021

Qinglei Gao
Jianqing Zhu
Weidong Zhao
Yi Huang
Ruifang An
Hong Zheng
Pengpeng Qu
Li Wang
Qi Zhou
Danbo Wang
Ge Lou
Jian Wang
J.S.H. Low
Beihua Kong
Rutie Yin
Xing Xie
Jihong Liu
Wei Sun
Rongyu Zang
Ding Ma

e17526Background: In patients with platinum-sensitive recurrent serous ovarian cancer, maintenance monotherapy with the poly (ADP-ribose) polymerase inhibitor (PARPi) olaparib, significantly improv...

Keywords:

Olaparib
platinum sensitive
Internal medicine
Oncology
in patient
serous ovarian cancer
Ovarian cancer
Medicine
open label study
polymerase inhibitor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations